Yao Zhang
A State Key Laboratory For The Chemistry And Molecular Engineering Of Medicinal Resources
Guilin, China
Guilin, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
The expression of lncRNA XIST in hepatocellular carcinoma cells and its effect on biological function.
Journal: Journal of B.U.ON. : official journal of the Balkan Union of Oncology
Published: December 05, 2020
HSA-based multi-target combination therapy: regulating drugs' release from HSA and overcoming single drug resistance in a breast cancer model.
Journal: Drug delivery
Published: January 20, 2018
Design of an Anticancer Copper(II) Prodrug Based on the Lys199 Residue of the Active Targeting Human Serum Albumin Nanoparticle Carrier.
Journal: Molecular pharmaceutics
Published: May 05, 2017
Design an anticancer copper(II) pro-drug based on the flexible IIA subdomain of human serum albumin.
Design an anticancer copper(II) pro-drug based on the flexible IIA subdomain of human serum albumin.
Journal: Journal of inorganic biochemistry
Published: November 13, 2016
Multidrug Delivery Systems Based on Human Serum Albumin for Combination Therapy with Three Anticancer Agents.
Journal: Molecular pharmaceutics
Published: July 26, 2016
Developing an anticancer copper(II) pro-drug based on the nature of cancer cell and human serum albumin carrier IIA subdomain: mouse model of breast cancer.
Journal: Oncotarget
Published: April 05, 2016
Developing an Anticancer Copper(II) Pro-Drug Based on the His242 Residue of the Human Serum Albumin Carrier IIA Subdomain.
Journal: Molecular pharmaceutics
Published: March 29, 2016
Developing Anticancer Copper(II) Pro-drugs Based on the Nature of Cancer Cells and the Human Serum Albumin Carrier IIA Subdomain.
Journal: Molecular pharmaceutics
Published: September 11, 2015
Structural basis of non-steroidal anti-inflammatory drug diclofenac binding to human serum albumin.
Journal: Chemical biology & drug design
Published: February 02, 2015
Binding and Anticancer Properties of Plumbagin with Human Serum Albumin.
Journal: Chemical biology & drug design
Published: August 20, 2014
Enhancing the copper(II) complexes cytotoxicity to cancer cells through bound to human serum albumin.
Journal: Journal of inorganic biochemistry
Published: August 19, 2014
Structural basis and anticancer properties of ruthenium-based drug complexed with human serum albumin.
Journal: European journal of medicinal chemistry
Published: February 15, 2014
Last Updated: 09/26/2026